Marker Therapeutics, Inc.
MRKR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001094038
No open-market purchases or sales by Marker Therapeutics, Inc. insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $5.84M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Marker Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −1 vs. Q2 2023
- Shares held
- 1.94M
- +76.4K (+4.1%) vs. Q2 2023
- Total value
- $8.82M
- +$3.04M (+52.6%) vs. Q2 2023
- New holders
- 1
- 9 more added
- Sold out
- 2
- 7 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MRKR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $5.84M |
| Q1 2026 | 35 | $5.07M |
| Q4 2025 | 36 | $6.03M |
| Q3 2025 | 32 | $3.09M |
| Q2 2025 | 31 | $5.22M |
| Q1 2025 | 32 | $5.04M |
| Q4 2024 | 33 | $11.0M |
| Q3 2024 | 28 | $5.67M |
| Q2 2024 | 28 | $10.9M |
| Q1 2024 | 28 | $8.52M |
| Q4 2023 | 26 | $10.9M |
| Q3 2023 | 28 | $8.82M |
| Q2 2023 | 29 | $5.78M |
| Q1 2023 | 30 | $1.41M |
| Q4 2022 | 48 | $5.21M |
| Q3 2022 | 47 | $7.54M |
| Q2 2022 | 50 | $7.35M |
| Q1 2022 | 52 | $10.3M |
| Q4 2021 | 65 | $25.1M |
| Q3 2021 | 63 | $44.7M |
| Q2 2021 | 74 | $75.8M |
| Q1 2021 | 74 | $56.9M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Marker Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 31 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 12 | $55 | 0.00% | −72−85.7% | Reduced |
| Versant Capital Management, Inc | 15 | $68 | 0.00% | 00.0% | Unchanged |
| Huntington National Bank | 70 | $318 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 93 | $422 | 0.00% | −1,414−93.8% | Reduced |
| Group One Trading, L.P. | 178 | $819 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 280 | $1.27K | 0.00% | +3+1.1% | Added |
| MCF Advisors LLC | 609 | $2.77K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 627 | $2.85K | 0.00% | −2,165−77.5% | Reduced |
| US Bancorp | 839 | $3.81K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 834 | $3.84K | 0.00% | +711+578.0% | Added |
| BlackRock Inc. | 1,364 | $6.19K | 0.00% | −544−28.5% | Reduced |
| Morgan Stanley | 1,940 | $8.81K | 0.00% | 00.0% | Unchanged |
| Riggs Asset Managment Co. Inc. | 2,350 | $10.7K | 0.00% | −200−7.8% | Reduced |
| Bank of America Corp | 3,220 | $14.6K | 0.00% | −824−20.4% | Reduced |
| Advisor Group Holdings, Inc. | 10,412 | $47.3K | 0.00% | +5,965+134.1% | Added |
| Northern Trust Corp | 10,881 | $49.4K | 0.00% | 00.0% | Unchanged |
| Matrix Asset Advisors Inc | 15,000 | $68.1K | 0.01% | −25,000−62.5% | Reduced |
| Creative Planning | 17,312 | $78.6K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 19,748 | $90.8K | 0.00% | +1,000+5.3% | Added |
| Dimensional Fund Advisors LP | 20,278 | $93.3K | 0.00% | +20,278 | New |
| Renaissance Technologies LLC | 40,250 | $183.0K | 0.00% | +8,300+26.0% | Added |
| Wedbush Securities Inc | 58,062 | $264.0K | 0.01% | +15,562+36.6% | Added |
| Geode Capital Management, LLC | 60,047 | $276.3K | 0.00% | +2,296+4.0% | Added |
| Ar Asset Management Inc | 70,700 | $321.0K | 0.09% | +30,000+73.7% | Added |
| Vanguard Group Inc | 221,082 | $1.00M | 0.00% | +55,483+33.5% | Added |
| Aisling Capital Management LP | 314,286 | $1.43M | 0.59% | 00.0% | Unchanged |
| NEA Management Company, LLC | 1,071,428 | $4.86M | 0.38% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,472−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −12,469−100.0% | Sold out |